Alder Biopharma (ALDR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALDR | GPCR | VRDN | ||
| Company | Alder Biopharma | Structure Therapeutics Inc | Viridian Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 18.95 | 28.53 | 18.92 | ||
| High | 19.12 | 29.08 | 19.77 | ||
| Low | 18.83 | 27.78 | 18.85 | ||
| Last | 18.88 | 28.58 | 19.67 | ||
| Change | -0.04 | +0.68 | +0.64 | ||
| % Change | -0.21% | +2.44% | +3.36% | ||
| Volume | 29,121,700 | 697,100 | 1,089,400 | ||
| 20-Day Average Volume | 5,270,225 | 1,003,640 | 1,761,475 | ||
| Previous Close | 18.92 | 27.90 | 19.03 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 18.86 | 32.17 | 19.96 | ||
| 20-Day Raw Stochastic | 48.94% | 23.05% | 39.61% | ||
| 20-Day Relative Strength | 79.65% | 39.18% | 46.77% | ||
| Weighted Alpha | -4.50 | -50.65 | -26.19 | ||
| Today's Opinion | 88% Buy | 100% Sell | 8% Buy | ||
| Previous Opinion | 88% Buy | 100% Sell | 8% Buy | ||
| Last Month's Opinion | 24% Buy | 88% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.21% since 10/14/19 | -7.81% since 12/16/24 | -8.68% since 12/16/24 | ||
| Low | 18.83 on 10/21/19 | 26.23 on 12/18/24 | 17.06 on 12/19/24 | ||
| High | 19.12 on 10/21/19 | 31.68 on 12/17/24 | 22.01 on 12/17/24 | ||
| 1-Month | |||||
| %Chg | +1.29% since 09/20/19 | -14.46% since 11/22/24 | -2.62% since 11/22/24 | ||
| Low | 18.60 on 09/23/19 | 26.23 on 12/18/24 | 17.06 on 12/19/24 | ||
| High | 19.12 on 10/21/19 | 36.42 on 12/09/24 | 23.65 on 12/16/24 | ||
| 3-Month | |||||
| %Chg | +92.26% since 07/19/19 | -32.51% since 09/23/24 | -6.87% since 09/23/24 | ||
| Low | 8.39 on 09/09/19 | 26.23 on 12/18/24 | 17.06 on 12/19/24 | ||
| High | 19.12 on 10/21/19 | 45.22 on 09/24/24 | 27.20 on 11/12/24 | ||
| 6-Month | |||||
| %Chg | +48.90% since 04/18/19 | -37.28% since 06/21/24 | +56.48% since 06/21/24 | ||
| Low | 8.39 on 09/09/19 | 26.23 on 12/18/24 | 11.85 on 07/03/24 | ||
| High | 19.12 on 10/21/19 | 47.48 on 07/16/24 | 27.20 on 11/12/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,582,842 | 1,636,519 | 1,558,120 | ||
| Shares Outstanding, K | 83,837 | 57,261 | 79,213 | ||
| Annual Sales | 0 | 0 | 310,000 | ||
| Annual Net Income | -296,430,000 | -89,620,000 | -237,730,000 | ||
| Last Quarter Sales | N/A | 0 | 90,000 | ||
| Last Quarter Net Income | N/A | -33,980,000 | -76,690,000 | ||
| 60-Month Beta | 2.64 | -3.41 | 1.05 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.20 on 11/13/24 | -1.15 on 11/12/24 | ||
| Latest Earnings Date | 11/04/19 | 11/12/24 | 11/11/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||